Therapeutic applications of noncoding RNAs

Current Opinion in Cardiology
Michael V G Latronico, Gianluigi Condorelli

Abstract

In this review, we summarize the basic principles underlying the therapeutic use of nonprotein coding (nc)RNAs, such as microRNA (miRNA) and long noncoding RNA, in the cardiovascular field, focusing, where possible, on recent advances that may lead to translation to the clinic for heart failure. The number of individual miRNAs associated with a given aspect of heart disease is increasing rapidly, as is the data on miRNA profiles in normal and diseased myocardium. Less is known on the role of long noncoding RNA, and to date only a few have been studied in the heart. Novel oligonucleotide-based therapies have started to trickle into the clinic, but strategies focusing on ncRNA are still in a clinical/preclinical trial phase. The discovery of functional ncRNAs is leading to a better understanding of the mechanisms underlying cardiovascular physiology. Dysregulation of ncRNAs is being increasingly associated with many diseases affecting the heart and in certain instances may have a pathogenic role. Therapeutic intervention aimed at opposing ncRNA misexpression has been widely demonstrated to be effective in blunting disease in animal models, and may thus have potential in the clinical setting.

References

Apr 1, 1997·Antisense & Nucleic Acid Drug Development·J SummertonM Partridge
Aug 19, 2003·RNA·Ya-Lin Chiu, Tariq M Rana
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
May 13, 2006·Nucleic Acids Research·Scott DavisChristine Esau
May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
Dec 26, 2007·Methods : a Companion to Methods in Enzymology·Christine C Esau
Mar 28, 2008·Nature·Joacim ElménSakari Kauppinen
Jun 6, 2008·Journal of Virology·Magalie Penaud-BudlooRichard O Snyder
Aug 21, 2008·Angewandte Chemie·Kiranmai GumireddyAlexander Deiters
Jun 10, 2010·Journal of the American Chemical Society·Douglas D YoungAlexander Deiters
Sep 22, 2010·RNA·Margaret S Ebert, Phillip A Sharp
Mar 3, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nagesh PulicherlaAravind Asokan
Mar 23, 2011·Nature Genetics·Susanna ObadSakari Kauppinen
Mar 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Phong TrangFrank J Slack
Mar 31, 2011·Nucleic Acids Research·Michael P GantierBryan R G Williams
Aug 2, 2011·Vascular Pharmacology·Dorothee Hartmann, Thomas Thum
Nov 5, 2011·Circulation Research·Thomas G HullingerEva van Rooij
Aug 2, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jasmina LovricMauro Giacca
Oct 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Bianca C BernardoJulie R McMullen
Oct 20, 2012·Nature Reviews. Drug Discovery·Eva van Rooij, Eric N Olson
Jan 3, 2013·The Journal of Clinical Investigation·Daniel Quiat, Eric N Olson
Jan 16, 2013·Current Pharmaceutical Design·Catherine GebhardJean-Claude Tardif
Feb 27, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anja GeislerHenry Fechner
Mar 29, 2013·The New England Journal of Medicine·Harry L A JanssenMichael R Hodges
Aug 31, 2013·Circulation Research·Regalla Kumarswamy, Thomas Thum
Oct 30, 2013·Human Gene Therapy·Aravind Asokan, R Jude Samulski
Feb 22, 2014·Circulation Research·Kun WangPei-Feng Li
Mar 4, 2014·Journal of the American College of Cardiology·Gianluigi CondorelliElena Cavarretta
Mar 15, 2014·Nucleic Acids Research·Alessandro LaganàCarlo Maria Croce
Sep 10, 2014·Nature Reviews. Cardiology·Thomas Thum
Sep 23, 2014·EMBO Molecular Medicine·Rusty L MontgomeryEva van Rooij

❮ Previous
Next ❯

Citations

Feb 7, 2016·Biochimica Et Biophysica Acta·Corinne Bischof, Jaya Krishnan
Sep 25, 2015·Future Medicinal Chemistry·Bianca C BernardoJulie R McMullen
Sep 14, 2016·Biomedical Journal·Sophia J Häfner, Anders H Lund
Jun 2, 2017·Experimental and Therapeutic Medicine·Yifei ZhangXiaojing Song
Apr 19, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xu ZhouNenghui Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical modifications
chip

Software Mentioned

miR
Synth

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

International Journal of Molecular Sciences
Federica CaloreMichela Garofalo
Current Heart Failure Reports
Michael V G Latronico, Gianlugi Condorelli
International Journal of Molecular Sciences
Claudio IaconettiCiro Indolfi
© 2021 Meta ULC. All rights reserved